Phase one/two study of focal salvage high-dose-rate brachytherapy for patient with PSA-failure after radiotherapy for prostate cancer

Phase one/two study of focal salvage high-dose-rate brachytherapy for patient with PSA-failure after radiotherapy for prostate cancer - Salvage high-dose-rate brachytherapy for local recurrent prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013140

Enrollment

Registered

2014-02-24

Start date

2014-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent prostate cancer after radiotherapy

Interventions

focal high-dose-rate brachytherapy

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: local recurrent prostate cancer after external radiotherapy less than 76Gy,without distant metastasis

Exclusion criteria

Exclusion criteria: prostate cancer with hormon reflactoly

Design outcomes

Primary

Measure	Time frame
side effect	—

Secondary

Measure	Time frame
clinical results	—

Countries

Japan

Contacts

Public ContactJunichi Hiratsuka

Kawasaki Medical School Radiation Oncology

hiratuka@med.kawasaki-m.ac.jp086-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026